RENOWN NEWSROOM

Kerry Kelly, MPH has joined Renown Health as Community Health Program Manager. Ms. Kelly comes to Renown from the Food Bank of Northern Nevada where she served as Director of Programs and Community Engagement. She had previously been employed as a Medical Practice Supervisor with Renown Children’s, responsible for managing the day-to-day operations of three ambulatory pediatrics medical practices. With her extensive background in public health and community engagement, Kerry brings a wealth of experience to the role of Community Health Program Manager. Ms. Kelly will play a pivotal role in fostering Community Benefit health initiatives that address northern Nevada’s most pressing health needs, reduce health disparities, promote community wellness, and improve access to care for vulnerable populations. “We are excited to welcome Kerry as our new Community Health Program Manager,” said Suzanne Bharati Hendery, MA, APR, Chief Communications & Customer Officer. “Community is at the center of our mission, and we embrace our commitment to make a genuine difference in creating a healthier Nevada for all. Kerry has a passion for community health and a proven track record in driving initiatives that promote health equity, increase insurance coverage, and enhance health outcomes. The vital role that Renown Health plays as the only local, not-for-profit, charitable healthcare network in Reno will be strengthened by her commitment. We look forward to the innovative strategies and partnerships she will bring to further enhance the health of the community we serve.” Kerry completed her Master’s of Public Health with an emphasis in Community Health Education at San José State University and her BA in Psychology, Community Health Science at the University of Nevada, Reno. Kerry will report directly to Sierra Kelly Martinez, MPH, Director of the Customer Engagement Center. Renown Health has long-standing commitment to the community than spans more than 160 years. This commitment has grown and evolved through significant thought and care in considering our community’s most pressing health needs. One way this is done is through conducting a periodic, comprehensive Community Health Needs Assessment (CHNA). Through the CHNA process, Renown Health identifies the greatest health needs, and ensures resources are appropriately directed toward outreach, prevention, education, and wellness opportunities where the greatest impact can be realized. For more information on the most current Community Health Needs Assessment, visit renown.org/About/Community-Commitment/Community-Health-Needs-Assessment. Renown Health also funds and supports NevadaTomorrow.org, a website that can be accessed free of charge, and provides residents with up-to-date sources of quality-of-life data (such as health and socio-economic information), key reports that describe our community’s current quality of life needs, promising practices to improve people’s overall quality of life, and quality of life improvement efforts in our community. Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,200 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health

Read More About Kerry Kelly, MPH Selected as Community Health Program Manager for Renown

Renown Medical Group is thrilled to welcome two distinguished breast surgical oncologists, Colleen O'Kelly-Priddy, MD and Michelle K. Chu, MD to the team. These highly skilled breast surgeons will solely focus on providing breast care and therefore play a pivotal role in Renown Health’s William N. Pennington Cancer Institute’s commitment to provide subspecialized care to the people living in our community and beyond. Dr. Colleen O'Kelly-Priddy is a fellowship-trained, board-certified breast surgical oncologist with an impressive background in breast cancer surgery. Dr. Priddy was born at Washoe Medical Center (which later became Renown Regional Medical Center) and grew up in Susanville, CA before attending Stanford University for her undergraduate studies. She is a graduate of the University of Nevada, Reno School of Medicine. "I am thrilled to return to Reno to help increase access to world-class surgical breast cancer care,” said Dr. Priddy. “My focus is to provide exceptional care, particularly for young people with breast cancer. I am excited to continue my mission here in northern Nevada." Dr. Michelle K. Chu, a board-certified general surgeon, brings her extensive experience in advanced breast cancer treatment to the Renown team. Dr. Chu received her undergraduate degree from the University of Pennsylvania and her medical degree from Western Reserve School of Medicine in Cleveland, OH. Dr. Chu specializes in oncoplastic breast conserving surgery and nipple sparing mastectomies. "I believe in tailoring treatment options to each patient's unique needs,” Dr. Chu said. “Whether it's preserving the natural shape of the breast or supporting the 'Going Flat' movement, our team strives to provide the best possible outcome for every patient." The newest addition to the William N. Pennington Cancer Institute, Renown Breast Surgery Care provides comprehensive breast surgery care at 1500 E. 2nd Street in Reno, adjacent to the Renown Regional Medical Center campus. "Breast cancer accounts for approximately 20% of newly diagnosed cancer cases in Washoe County, with roughly 520 new cases annually, establishing it as the most prevalent cancer type within our community,” says Brian Erling, MD, MBA, President & CEO, Renown Health. “We are proud, as the community’s largest not-for-profit healthcare system, to invest in cancer prevention and early diagnoses, including mammography screening and genetic research. For those diagnosed with breast cancer, Renown now offers two superb breast surgeons specializing in breast preservation surgery, and a breast surgery center providing comprehensive, compassionate care. Our goal is to save women’s lives, save families and ensure better care and better outcomes. This is a major step forward for women’s healthcare and our community.” As part of this expansion, Renown is assuming operations of Reno Surgical Advocates, a respected private practice in Reno. "Access to expert breast cancer care close to home is crucial, and our dedicated team at Renown Breast Surgery Care will work tirelessly to provide the highest level of care to patients while working closely with our other cancer specialists," said Max Coppes, MD, PhD, MBA, Director, William N. Pennington Institute for Cancer. “With the exceptional expertise of Dr. Colleen O'Kelly-Priddy and Dr. Michelle K. Chu, coupled with our state-of-the-art facility; Renown Health is a true partner in the fight against breast cancer in northern Nevada.” "People are increasingly relocating to northern Nevada, and in fact, Washoe County experienced a 2.1% population growth from April 2020 to July 2022. Consequently, although northern Nevada does not exhibit an above-average cancer rate, we are observing a rise in cases at our facilities," said Dr. Lee Schwartzberg, MD, FACP, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute. "Renown Health is positioned to meet this growing demand, and we take pride in consistently adding nationally renowned healthcare providers to our team to save the lives of women in northern Nevada.     About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

Read More About Saving More Lives; Renown Expands Breast Cancer Care, Adding Two Best-In-Class Breast Surgeons

During National Healthcare Week, clinical providers who are “Best of the Best” being honored for demonstrating exceptional communications skills in their clinical practice, as awarded by you, their patients. “Amazing! Phenomenal! Thank you for always showing genuine concern. You are kind, considerate and caring. You are interested in me. You are the best doctor/nurse practitioner I have ever had. I trust you with my life. You act on things right away. You are awesome. You have saved my life, and my family. You are knowledgeable, thorough, intelligent, and compassionate. You are my favorite. You are my angel. You have made me better. You always make me feel like a success, even if I could have tried harder. I love you. I thank you.” These are some of the comments made by patients regarding their doctors and advanced practice providers who will be honored next week by the Patient & Family Advisory Council and Renown Health with a special breakfast celebration in south Reno. In honor of National Healthcare Week, Renown Medical Group, which offers primary and specialty care at locations in Reno, Sparks, Carson City, Fallon, Fernley, and Silver Springs will honor 37 physicians and advanced practice providers at the Dr. John Spellman Excellence in Patient Communications Award Celebration. This annual award, supported by the Renown Health Foundation and a donor family, honors clinicians who demonstrate exceptional communications skills in their clinical practice, as awarded by their patients. Recipients of this award are ranked in the top ten percent nationally in provider communication for 2022, as measured by over 11 thousand patients who responded nationally to the Centers for Medicare & Medicaid Services’ (CG-CAPHS) or Clinician and Group Consumer Assessment of Healthcare Providers and Systems and over 14,000 local patients who gave them top scores on the national patient experience survey. Patients were asked if their medical providers explained things in a way they could understand; if they listened carefully; if they showed respect for what they had to say; if they spent enough time with them; if they read their medical records; if they ordered tests and followed up with them on their results; and to give them a rating on a scale of 1 to 10, where 10 was the highest score. “These incredible medical providers set the gold standard for excellent communications with patients, scoring in the top 10% nationally for compassion, caring, competency and communications,” said Brian Erling, MD, MBA, President & CEO of Renown Health. “We are extremely proud of them and their outstanding dedication to patients, families and our community.” The awards will be given by his family in remembrance of the late Dr. John W. Spellman, human rights advocate, scholar and professor. Dr. Spellman treasured kindness, scholarship, debate and medical providers who demonstrated exceptional communications skills and held their patients in the highest regard. The Recipients of the 2022 Dr. John Spellman Excellence in Patient Communications Award are: Christina Alsop, DNP, AOCNP, Oncology Nurse Practitioner, William N. Pennington Cancer Institute at Renown Pamela Burgio, APRN, Renown Primary Care Jennifer Brown, APRN, Pulmonary & Sleep Medicine Stephanie Carlesen, DNP, Renown Institute for Heart & Vascular Health Carolyn Dennehey, MD, Rheumatology Benjamin Ebner, MD, Renown Institute for Heart & Vascular Health Christopher Driscoll, MD, Pediatrics, Renown Children’s Hospital Kerac Falk, MD, FACOG, Renown Women’s Health Michael Hardacre, MD, Radiation Oncology, William N. Pennington Cancer Institute at Renown Robin Hollen, DNP, FNP-C, APRN, M.Ed., MSN, Breastfeeding Medicine Nurse Practitioner, Renown Women’s Health James Martin Johnston, MD, Pediatric Hematology/Oncology, Renown Children’s Hospital Stephanie Jones, DO, Physical Medicine/Rehabilitation Charlotte Kermode, APRN, Renown Primary Care Michele Kiser, MD, Renown Primary Care Matthew Klippenstein, MD, Renown Primary Care Anamarie Manea, MD, Pediatric Endocrinology, Renown Children’s Hospital Marie McCoramck, MD, Renown Primary Care Catherine Mindeguia, APRN, Renown Primary Care Dean Miyagawa, MD, Internal Medicine, Renown Primary Care Amanda Morgan, MD, Pulmonary Medicine, Renown Medical Group Cecelia O’Dowd, MD, Renown Primary Care Kasie Reynolds, APRN, Renown Children's Hospital, Behavioral Health Jocelyn Schneider, APRN, Renown Institute for Heart & Vascular Health Vanessa Slots, MD, Renown Pediatrics Daniel Spogen, MD, Renown UNR Primary Care, Sports Medicine Jennifer Simcox, APRN, Renown Primary Care Mark Stovak, MD, Renown UNR Primary Care, Sports Medicine Shining Sun, MD, Renown Institute for Heart & Vascular Health Jennifer Sutton, MD, Radiation Oncology, William N. Pennington Cancer Institute at Renown Robert Swackhamer, MD, Renown Institute for Heart & Vascular Health Carl Thomas, MD, Renown Primary Care Katherine Thyssen, DO, Geriatric Medicine, Renown Primary Care Ly Vu, MD, Renown Primary Care Scott Michael Wallace, MD, Renown Pediatrics Kristin Wilson, MD, Renown Pediatrics Bryan Young MD, Internal Medicine, Renown Primary Care Jacob Zucker, MD, Pediatric Hematology & Oncology, Renown Children’s Hospital   Since 2018, Renown Medical Group has posted thousands of verified patient ratings and comments of their employed providers online and viewable by the public at renown.org. “Our goal is to consistently exceed customer expectations, every day, and with every encounter. At Renown, we embrace transparency and empower patients,” says Rahul Mediwala, MD, CEO of Renown Medical Group. Dr. Mediwala should know – he is also a highly rated physician by his patients, has practiced for more than 20 years, and sees the ratings program as another way to support employed physicians and providers at Renown Health. Only patients who’ve had an outpatient visit with a Renown Medical Group provider may be selected to receive a survey from CH-CAHPS. This way, Renown can confirm the results are from patients who have been seen by the provider. All comments are posted anonymously, and patients are asked for their permission to use their comments. Feedback is shared with every provider. Renown Health is integrated with the University of Nevada, Reno School of Medicine, Nevada’s first medical school, which serves to enhance the health of the community through increased access to care, innovative health care delivery, expansion of clinical research and training for the next generation of physicians and health care professionals. Almost 700 Renown Medical Group primary care and specialty providers are currently accepting new patients and accept most health insurance plans, including Renown’s not-for-profit insurance plan, Hometown Health. To find the doctor or provider that is best for you visit renown.org, self-schedule with your established provider at MyChart.Renown.org or schedule an appointment with a Renown Medical Group or University Health provider by calling our agents available by phone- Wed-Fri: 7 a.m. to 7 p.m., Sat-Sun: 7 a.m. to 6 p.m., at 775-982-5000. Renown Health is currently hiring in all areas. Search for a new career opportunity and apply online at careers.renown.org. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

Read More About Reno Home to 37 of the Nation's Best Patient Communicators

Recognized as one of the world’s leading breast cancer experts as a 2023 Legends in Cancer Honoree Dr. Lee Schwartzberg, FACP, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute at Renown, was honored as the 2023 Legends in Cancer honoree at this year's Best of Breast conference for his contributions to the field of breast cancer. The conference took place on Jan. 21 and 22. Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 36 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates across the country, and here in Washoe County have declined progressively due to advancements in treatment, detection, and care. Each year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 in men. Here in Washoe County, more than 21 deaths per 100,000 females are due to breast cancer, a significant decrease since 2012 when 24 deaths per 100,000 females were reported. Dr. Schwartzberg was selected for this award based on his unique and vast contributions to advancing science and patient care, including his major research interests such as therapeutic approaches to breast cancer, targeted therapies, and supportive care. The selection committee evaluates each candidates’ body of work — including contributions to the field of breast cancer in clinical research, patient care, mentoring and community service — before deciding on an honoree. “Dr. Schwartzberg is deserving of this honor. As a national expert in the study and treatment of breast cancer, precision medicine and supportive care, Dr. Schwartzberg is transforming cancer care and improving the lives of all of us in northern Nevada. As the most preferred cancer program in the region, we are working with the support of donors like The William N. Pennington Foundation to recruit additional oncology specialists and cancer science researchers to become the first National Cancer Institute-designated comprehensive cancer care center in Nevada," said Dr. Brian Erling, MBA, CEO of Renown Health. “The incredible care that comes from the William N. Pennington Cancer Institute is possible because of nationally recognized oncologists like Dr. Schwartzberg.” “Dr. Schwartzberg completed fellowship training in medical oncology and hematology at Memorial Sloan Kettering Cancer Center in New York, where he also served as Chief Medical Resident and was a founding member of the institutional ethics committee,” add Paul J. Hauptman, MD, dean of the University of Nevada, Reno School of Medicine and chief academic officer for Renown Health. “We are proud that he serves as a professor of clinical medicine at the University of Nevada, Reno School of Medicine. His research interests include supportive care, precision medicine and patient-reported outcomes in breast cancer and he has published over 300 peer-reviewed manuscripts, book chapters and monographs.” “It is an honor to work with Dr. Schwartzberg and his patients have the most incredible things to say about the care he provides.” said Dr. Max J Coppes, PhD, MBA, Director, William N. Pennington Cancer Institute, Renown Health. “He understands that his patients are going through one of the most challenging times in their lives. Dr. Schwartzberg brings decades of experience to our community, is a great listener, and treats everyone with compassion and dignity. We are so proud to have him at Renown.” The Best of Breast Conference is an innovative medical education program that gathers the world's leading breast cancer experts to discuss cases with high-risk characteristics, adjuvant and metastatic treatment advances, interdisciplinary care and survivorship and recurrence — all while incorporating data from the major oncologic annual meetings. Dr. Schwartzberg has been selected to chair Total Health’s spring oncology education retreat in Lake Tahoe on April 15 and 16. The event’s comprehensive agenda will allow attendees to engage with the latest research and strategies in cancer care while networking with colleagues from across the country in a peaceful setting. Additional conference information is available here. For women, breast exams using mammography after 40 years old is recommended. For those age 75 and older, a mammogram is recommended every year. Having regular mammograms can lower the risk of dying from breast cancer. Both 3-D digital mammography and whole breast ultrasounds are available at the Greenberg Breast Health Center at Renown and other locations across northern Nevada. The Affordable Care Act makes breast cancer screening and counseling free. All health plans must cover these benefits at no cost to you. Renown MyChart app users can self-schedule a mammogram appointment. To call to schedule, dial 775-982-8100. At the William N. Pennington Cancer Institute at Renown Health, patients receive innovative, personalized treatment to fight cancer while an experienced team provides the support and technology to maintain the highest quality of life. The Renown team’s clinical expertise and advanced treatment options blend evidence-based care with leading-edge research to improve cancer outcomes for every patient and family. For more information or a referral, visit renown.org/cancer. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. About Total Health Total Health is a medical information company of planning experts who produce tailored content, courses, and conferences for oncology healthcare providers, virtual and in-person. Total Health believes knowledge is power. Its mission is to give oncology healthcare providers an educational experience that equips them with the latest strategies to improve clinical practice and treatment outcomes.

Read More About Dr. Lee Schwartzberg Honored With 2023 Legends in Cancer Award

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Read More About Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)